BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 7030649)

  • 1. Localized bullous pemphigoid with negative immunofluorescence.
    Silber JG; Brody N
    Cutis; 1981 Nov; 28(5):562, 565. PubMed ID: 7030649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predominance of IgG4 in prodromal bullous pemphigoid.
    Lamb PM; Patton T; Deng JS
    Int J Dermatol; 2008 Feb; 47(2):150-3. PubMed ID: 18211485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of human monoclonal anti-basement membrane zone (BMZ) antibodies from a patient with bullous pemphigoid (BP) by Epstein-Barr virus transformation. Analyses of the heterogeneity of anti-BMZ antibodies in BP sera using them.
    Sugi T; Hashimoto T; Hibi T; Nishikawa T
    J Clin Invest; 1989 Oct; 84(4):1050-5. PubMed ID: 2551921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bullous pemphigoid: a correlative study of autoantibodies, circulating immune complexes and dermo-epidermal deposits.
    Gomes MA; Dambuyant C; Thivolet J; Bussy R
    Br J Dermatol; 1982 Jul; 107(1):43-51. PubMed ID: 6809029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of leukocyte adherence at the basement membrane zone with subsequent activation of their metabolic pathway by pemphigoid antibodies and complement.
    Iwatsuki K; Tagami H; Yamada M
    Acta Derm Venereol; 1983; 63(4):290-5. PubMed ID: 6195859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complement fixing ability of anti-basement membrane zone IgG subclass of herpes gestationis and bullous pemphigoid.
    Suzuki M; Watanabe C; Yaoita H
    Acta Derm Venereol; 1989; 69(1):6-11. PubMed ID: 2563610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum and blister fluid immune complexes in bullous pemphigoid: detection with C1q and monoclonal rheumatoid factor.
    Jordon RE; Struve MF; Bushkell LL
    Clin Exp Immunol; 1981 Jul; 45(1):29-36. PubMed ID: 7030538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of serum anti-basement membrane zone antibody and malignancy in bullous pemphigoid.
    Ahmed AR; Amerian ML
    Dermatologica; 1985; 171(2):82-5. PubMed ID: 3899759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of chemically split tissue in the detection of circulating anti-basement membrane zone antibodies in bullous pemphigoid and cicatricial pemphigoid.
    Kelly SE; Wojnarowska F
    Br J Dermatol; 1988 Jan; 118(1):31-40. PubMed ID: 3277659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of anti-basement membrane-zone antibody by peripheral blood leukocytes of pemphigoid patients.
    Ahmed AR; Stevens RH; Saxon A
    J Clin Immunol; 1982 Jul; 2(3):179-85. PubMed ID: 6811607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa.
    Minato H; Ishii N; Fukuda S; Wakasa T; Wakasa K; Sogame R; Hashimoto T; Horiguchi Y
    J Dermatol; 2011 Sep; 38(9):887-92. PubMed ID: 21366683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of sodium-chloride separated human skin in detection of circulating anti-basement membrane zone antibodies.
    Rasmussen HB; Brandrup F; Andersen J; Hagdrup H
    Acta Derm Venereol; 1989; 69(6):515-9. PubMed ID: 2575326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Trials on bulla induction by antibodies from bullous pemphigoid patients in vivo and in vitro].
    Lohrisch I; Noack H; Haustein UF; Sparmann G; Koch J
    Dermatol Monatsschr; 1985; 171(2):106-12. PubMed ID: 3884399
    [No Abstract]   [Full Text] [Related]  

  • 14. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods.
    Gammon WR; Inman AO; Wheeler CE
    J Invest Dermatol; 1984 Jul; 83(1):57-61. PubMed ID: 6376640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bullous pemphigoid autoantibodies are markers of corneal epithelial hemidesmosomes.
    Anhalt GJ; Jampel HD; Patel HP; Diaz LA; Jabs DA; Mutasim DF
    Invest Ophthalmol Vis Sci; 1987 May; 28(5):903-7. PubMed ID: 3553061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunological study of patients with bullous pemphigoid.
    Hovmark A; Asbrink E
    Acta Derm Venereol; 1982; 62(3):201-4. PubMed ID: 6179358
    [No Abstract]   [Full Text] [Related]  

  • 17. Immune complexes in pemphigus and bullous pemphigoid.
    Ahmed AR; Moy RL; Chia D; Barnett EV
    Dermatologica; 1983; 166(4):175-80. PubMed ID: 6343146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum IgE levels in patients with bullous pemphigoid and its correlation to the activity of the disease and anti-basement membrane zone antibodies.
    Asbrink E; Hovmark A
    Acta Derm Venereol; 1984; 64(3):243-6. PubMed ID: 6204487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localized pemphigoid: a case report showing in situ deposition as well as presence in serum of IgG and IgA anti-basement membrane zone antibodies.
    Sugihara K; Dekio S; Tohgi K; Jidoi J
    J Dermatol; 1987 Feb; 14(1):73-6. PubMed ID: 3301954
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of IgG-subclass antibody determinations in bullous pemphigoid.
    Kumar V; Valeski JE; Chorzelski TP; Jablonska S
    J Clin Lab Anal; 1996; 10(6):432-4. PubMed ID: 8951615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.